Abstract
Expression of the PTEN tumor suppressor gene is abnormal in many human cancers. Loss of PTEN expression leads to the activation of downstream signaling pathways that have been associated with resistance to radiation. In non-small cell lung carcinoma (NSCLC), suppressed expression of PTEN is frequently due to methylation of its promoter region. In this study, we tested whether gene transfer of wild-type PTEN into an NSCLC cell line with a known methylated PTEN promoter, H1299, would increase its sensitivity to ionizing radiation. Pretreating H1299 cells with an adenoviral-mediated PTEN (Ad-PTEN)-expressing vector sensitized H1299 cells to radiation. To determine the mechanism responsible for radiosensitization, we first examined radiation-induced apoptosis, which was enhanced but did not correlate with radiosensitizing effect of Ad-PTEN. Therefore, we next examined the ability of Ad-PTEN to modulate the repair of radiation-induced DNA double-strand breaks (DSBs) using the detection of repair foci positive for γ-H2AX, a protein that becomes evident at the sites of each DSB and that can be visualized by immunofluorescent staining. Compared with controls, the repair of radiation-induced DSBs was retarded in H1299 cells pretreated with Ad-PTEN, consistent with the radiosensitizing effect of the vector. We conclude that signal transduction pathways residing primarily in the cytoplasm may intersect with DNA damage and repair pathways in the nucleus to modulate cellular responses to radiation. Elucidating the mechanisms responsible for this intersection may lead to novel strategies for improving therapy for cancers with defective PTEN.
Similar content being viewed by others
References
Girinsky T, Lubin R, Pignon JP, Chavaudra N, Gazeau J, Dubray B et al. Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival. Int J Radiat Oncol Biol Phys 1993; 25: 3–7.
West CM . Invited review: intrinsic radiosensitivity as a predictor of patient response to radiotherapy. Br J Radiol 1995; 68: 827–837.
Bellacosa A, Testa JR, Staal SP, Tsichlis PN . A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 1991; 254: 274–277.
Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995; 81: 727–736.
Burgering BM, Coffer PJ . Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995; 376: 599–602.
Kennedy SG, Wagner AJ, Conzen SD, Jordan J, Bellacosa A, Tsichlis PN et al. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev 1997; 11: 701–713.
Kennedy SG, Kandel ES, Cross TK, Hay N . Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol Cell Biol 1999; 19: 5800–5810.
Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91: 231–241.
del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G . Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997; 278: 687–689.
Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998; 282: 1318–1321.
Price BD, Youmell MB . The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage. Cancer Res 1996; 56: 246–250.
Rosenzweig KE, Youmell MB, Palayoor ST, Price BD . Radiosensitization of human tumor cells by the phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay. Clin Cancer Res 1997; 3: 1149–1156.
Boulton S, Kyle S, Yalcintepe L, Durkacz BW . Wortmannin is a potent inhibitor of DNA double strand break but not single strand break repair in Chinese hamster ovary cells. Carcinogenesis 1996; 17: 2285–2290.
Brognard J, Clark AS, Ni Y, Dennis PA . Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 2001; 61: 3986–3997.
Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275: 1943–1947.
Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 15: 356–362.
Li DM, Sun H . TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 1997; 57: 2124–2129.
Cantley LC, Neel BG . New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 1999; 96: 4240–4245.
Wick W, Furnari FB, Naumann U, Cavenee WK, Weller M . PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis. Oncogene 1999; 18: 3936–3943.
Rosser CJ, Tanaka M, Pisters LL, Tanaka N, Levy LB, Hoover DC et al. Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation. Cancer Gene Ther 2004; 11: 273–279.
Forgacs E, Biesterveld EJ, Sekido Y, Fong K, Muneer S, Wistuba et al. Mutation analysis of the PTEN/MMAC1 gene in lung cancer. Oncogene 1998; 17: 1557–1565.
Soria JC, Lee HY, Lee JI, Wang L, Issa JP, Kemp BL et al. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Clin Cancer Res 2002; 8: 1178–1184.
Zhang WW, Fang X, Branch CD, Mazur W, French BA, Roth JA . Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis. Biotechniques 1993; 15: 868–872.
Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C . PI3K/Akt and apoptosis: size matters. Oncogene 2003; 22: 8983–8998.
Sedelnikova OA, Rogakou EP, Panyutin IG, Bonner WM . Quantitative detection of (125)IdU-induced DNA double-strand breaks with gamma-H2AX antibody. Radiat Res 2002; 158: 486–492.
Schwartz JL, Mustafi R, Beckett MA, Weichselbaum RR . DNA double-strand break rejoining rates, inherent radiation sensitivity and human tumour response to radiotherapy. Br J Cancer 1996; 74: 37–42.
Shaw RJ, Cantley LC . Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 2006; 441: 424–430.
Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson DO, Wu H et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006; 441: 475–482.
MacPhail SH, Banath JP, Yu TY, Chu EH, Lambur H, Olive PL . Expression of phosphorylated histone H2AX in cultured cell lines following exposure to X-rays. Int J Radiat Biol 2003; 79: 351–358.
Taneja N, Davis M, Choy JS, Beckett MA, Singh R, Kron SJ et al. Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy. J Biol Chem 2004; 279: 2273–2280.
Okayasu R, Suetomi K, Ullrich RL . Wortmannin inhibits repair of DNA double-strand breaks in irradiated normal human cells. Radiat Res 1998; 149: 440–445.
Okayasu R, Takakura K, Poole S, Bedford JS . Radiosensitization of normal human cells by LY294002: cell killing and the rejoining of DNA and interphase chromosome breaks. J Radiat Res (Tokyo) 2003; 44: 329–333.
Puc J, Keniry M, Li HS, Pandita TK, Choudhury AD, Memeo L et al. Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell 2005; 7: 193–204.
Acknowledgements
This study was supported in part by Grants P01 CA06294 and P30 CA16672 from the National Cancer Institute and the Kathryn O'Connor Research Professorship (REM).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pappas, G., Zumstein, L., Munshi, A. et al. Adenoviral-mediated PTEN expression radiosensitizes non-small cell lung cancer cells by suppressing DNA repair capacity. Cancer Gene Ther 14, 543–549 (2007). https://doi.org/10.1038/sj.cgt.7701050
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7701050
- Springer Nature America, Inc.
Keywords
This article is cited by
-
Loss of PTEN-assisted G2/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer
Scientific Reports (2018)
-
Combining PARP inhibitors with radiation therapy for the treatment of glioblastoma: Is PTEN predictive of response?
Clinical and Translational Oncology (2017)
-
Involvement of miR-155/FOXO3a and miR-222/PTEN in acquired radioresistance of colorectal cancer cell line
Japanese Journal of Radiology (2017)
-
The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells
Cancer Gene Therapy (2014)
-
Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients
Tumor Biology (2014)